+91 9891296838 / 9811747774
Brain Tumors: Gleostine is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and/or radiotherapeutic procedures.
Hodgkin’s Lymphoma: Gleostine is indicated as a component of combination chemotherapy for the treatment of patients with Hodgkin’s lymphoma whose disease has progressed following initial chemotherapy. GLEOSTINE (lomustine) capsules Initial U.S. approval: 1976. GLEOSTINE (lomustine) capsules For Injection should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand GLEOSTINE (lomustine) capsules on prescription and Import License in Patient's Name only.
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
For Indian Patients, doctors and hospitals GLEOSTINE (lomustine) capsules can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Capsules: 5mg, 10 mg, 40 mg, and 100 mg.ReadMore
NextSource Biotechnology Gains FDA Approval for New 5 mg Strength of Gleostine® (Lomustine), an Anti-Cancer Chemotherapy Agent.
Dated: Jan 20, 2016